Cargando…
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
Assessing the risk of recurrent venous thromboembolism (VTE), particularly when patients are anticoagulated, remains a major challenge largely due to the lack of biomarkers. Blood was sampled from adult VTE patients recruited between January 2018 and September 2020, while receiving therapeutic antic...
Autores principales: | Wang, Julie, Lim, Hui Yin, Brook, Rowena, Lai, Jeffrey, Nandurkar, Harshal, Ho, Prahlad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925515/ https://www.ncbi.nlm.nih.gov/pubmed/35908244 http://dx.doi.org/10.1007/s11239-022-02686-6 |
Ejemplares similares
-
Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis
por: McLeod, Blake, et al.
Publicado: (2022) -
The Need for Individualized Risk Assessment in Cardiovascular Disease
por: Lim, Hui Yin, et al.
Publicado: (2022) -
Hypersensitivity reactions related to oxaliplatin (OHP)
por: Brandi, G, et al.
Publicado: (2003) -
New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010) -
New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016)